Esperion Therapeutics, Inc. 4 SEC Filings

Filed On	Filing
13 Jul 2026	Form 4: Hoffman Robert E., Director Returned 85,153 shares to the issuer · Disposed of 47,040 Stock Option (right to buy) (Disposition to Issuer)
13 Jul 2026	Form 4: Carroll J Martin, Director Returned 177,523 shares to the issuer · Disposed of 97,500 Stock Option (right to buy) (Disposition to Issuer)
13 Jul 2026	Form 4: Shepard Jay, Director Returned 164,472 shares to the issuer · Disposed of 97,500 Stock Option (right to buy) (Disposition to Issuer)
13 Jul 2026	Form 4: Fischer Seth H. Z., Director Returned 141,023 shares to the issuer · Disposed of 97,500 Stock Option (right to buy) (Disposition to Issuer)
13 Jul 2026	Form 4: Thompson John Craig, Director Returned 79,873 shares to the issuer · Disposed of 40,000 Stock Option (right to buy) (Disposition to Issuer)
13 Jul 2026	Form 4: Harlow John B. Jr., Chief Commercial Officer Returned 424,536 shares to the issuer
13 Jul 2026	Form 4: Looker Benjamin, Chief Legal Officer Returned 667,524 shares to the issuer · Disposed of 620,230 Stock Option (right to buy) (Disposition to Issuer)
13 Jul 2026	Form 4: Halladay Benjamin, Chief Financial Officer Returned 705,410 shares to the issuer · Disposed of 634,270 Stock Option (right to buy) (Disposition to Issuer)
13 Jul 2026	Form 4: Koenig Sheldon L., Director Returned 2,121,094 shares to the issuer · Disposed of 1,289,460 Stock Option (right to buy) (Disposition to Issuer) · Disposed of 753,000 Stock Option (right to buy (Disposition to Issuer)
18 Jun 2026	Form 4: Looker Benjamin, Chief Legal Officer Sold 11,824 shares ($37.3K)
18 Jun 2026	Form 4: Koenig Sheldon L., Director Sold 53,588 shares ($169K)
18 Jun 2026	Form 4: Halladay Benjamin, Chief Financial Officer Sold 10,773 shares ($34K)
01 Jun 2026	Form 4: Thompson John Craig, Director Received 79,873 shares as a grant or award
01 Jun 2026	Form 4: Shepard Jay, Director Received 79,873 shares as a grant or award
01 Jun 2026	Form 4: Hoffman Robert E., Director Received 79,873 shares as a grant or award
01 Jun 2026	Form 4: Fischer Seth H. Z., Director Received 79,873 shares as a grant or award
01 Jun 2026	Form 4: Carroll J Martin, Director Received 79,873 shares as a grant or award
18 Mar 2026	Form 4: Looker Benjamin, Chief Legal Officer Sold 5,708 shares ($15.4K)
18 Mar 2026	Form 4: Koenig Sheldon L., Director Sold 25,578 shares ($69.5K)
18 Mar 2026	Form 4: Halladay Benjamin, Chief Financial Officer Sold 6,424 shares ($17.4K)

Comments